Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZJD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,535
Award facts
- Contract value 100% obligated
- $45,534.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $45,534.74 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Xifaxan 550 mg tablets (60-count). This competitive, non-set-aside contract features firm fixed-price terms with an ultimate completion date of December 18, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Xifaxan is a non-absorbed antibiotic used primarily to treat traveler's diarrhea and certain gastrointestinal conditions, positioning this delivery order within the Defense Logistics Agency's pharmaceutical procurement operations supporting military and federal healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's significant federal contracting presence, combined with its demonstrated capability to fulfill competitive federal procurement requirements across multiple therapeutic domains, underscores its critical role as a pharmaceutical prime vendor for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4ZJD?
SPE2DR26F4ZJD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F4ZJD worth?
The government has obligated $45,535 on SPE2DR26F4ZJD.
Is contract SPE2DR26F4ZJD an order under another contract?
Yes. SPE2DR26F4ZJD is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZJD competed?
The extent of competition for SPE2DR26F4ZJD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award